ID   OAS1A_MOUSE             Reviewed;         367 AA.
AC   P11928; F2Z419; Q3UEC1; Q64440; Q91VI0;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   07-APR-2021, entry version 158.
DE   RecName: Full=2'-5'-oligoadenylate synthase 1A;
DE            Short=(2-5')oligo(A) synthase 1A;
DE            Short=2-5A synthase 1A;
DE            EC=2.7.7.84 {ECO:0000269|PubMed:12396720, ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:2171206, ECO:0000305|PubMed:27663720};
DE   AltName: Full=p42 OAS;
GN   Name=Oas1a; Synonyms=Oias1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3808949; DOI=10.1093/nar/14.24.10117;
RA   Ichii Y., Fukunaga R., Shiojiri S., Sokawa Y.;
RT   "Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-
RT   5A synthetase.";
RL   Nucleic Acids Res. 14:10117-10117(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CATALYTIC ACTIVITY.
RX   PubMed=2171206; DOI=10.1016/0042-6822(90)90292-y;
RA   Coccia E.M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E.,
RA   Battistini A., Fiorucci G., Orsatti R., Rossi G.B., Chebath J.;
RT   "A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells
RT   impairs EMCV but not VSV replication.";
RL   Virology 179:228-233(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=C57BL/6J; TISSUE=Spleen;
RX   PubMed=12396720; DOI=10.1089/10799900260286696;
RA   Kakuta S., Shibata S., Iwakura Y.;
RT   "Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene
RT   family.";
RL   J. Interferon Cytokine Res. 22:981-993(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NMRI; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-367, AND INDUCTION.
RX   PubMed=1709495; DOI=10.1093/nar/19.8.1917;
RA   Rutherford M.N., Kumar A., Nissim A., Chebath J., Williams B.R.G.;
RT   "The murine 2-5A synthetase locus: three distinct transcripts from two
RT   linked genes.";
RL   Nucleic Acids Res. 19:1917-1924(1991).
RN   [9]
RP   CATALYTIC ACTIVITY, INTERACTION WITH OAS1D, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=15899864; DOI=10.1128/mcb.25.11.4615-4624.2005;
RA   Yan W., Ma L., Stein P., Pangas S.A., Burns K.H., Bai Y., Schultz R.M.,
RA   Matzuk M.M.;
RT   "Mice deficient in oocyte-specific oligoadenylate synthetase-like protein
RT   OAS1D display reduced fertility.";
RL   Mol. Cell. Biol. 25:4615-4624(2005).
RN   [10]
RP   REVIEW.
RX   PubMed=17024523; DOI=10.1007/s00239-006-0073-3;
RA   Perelygin A.A., Zharkikh A.A., Scherbik S.V., Brinton M.A.;
RT   "The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for
RT   concerted evolution of paralogous Oas1 genes in Rodentia and
RT   Artiodactyla.";
RL   J. Mol. Evol. 63:562-576(2006).
RN   [11]
RP   REVIEW ON FUNCTION.
RX   PubMed=21142819; DOI=10.1089/jir.2010.0107;
RA   Kristiansen H., Gad H.H., Eskildsen-Larsen S., Despres P., Hartmann R.;
RT   "The oligoadenylate synthetase family: an ancient protein family with
RT   multiple antiviral activities.";
RL   J. Interferon Cytokine Res. 31:41-47(2011).
RN   [12]
RP   INDUCTION.
RX   PubMed=22305621; DOI=10.1016/j.virol.2011.11.025;
RA   Pulit-Penaloza J.A., Scherbik S.V., Brinton M.A.;
RT   "Activation of Oas1a gene expression by type I IFN requires both STAT1 and
RT   STAT2 while only STAT2 is required for Oas1b activation.";
RL   Virology 425:71-81(2012).
RN   [13]
RP   CATALYTIC ACTIVITY, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND INDUCTION.
RX   PubMed=27663720; DOI=10.1016/j.meegid.2016.09.018;
RA   Elkhateeb E., Tag-El-Din-Hassan H.T., Sasaki N., Torigoe D., Morimatsu M.,
RA   Agui T.;
RT   "The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.";
RL   Infect. Genet. Evol. 45:393-401(2016).
CC   -!- FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which
CC       plays a critical role in cellular innate antiviral response. In
CC       addition, it may also play a role in other cellular processes such as
CC       apoptosis, cell growth, differentiation and gene regulation.
CC       Synthesizes higher oligomers of 2'-5'-oligoadenylates (2-5A) from ATP
CC       which then bind to the inactive monomeric form of ribonuclease L (RNase
CC       L) leading to its dimerization and subsequent activation. Activation of
CC       RNase L leads to degradation of cellular as well as viral RNA,
CC       resulting in the inhibition of protein synthesis, thus terminating
CC       viral replication. Can mediate the antiviral effect via the classical
CC       RNase L-dependent pathway or an alternative antiviral pathway
CC       independent of RNase L. {ECO:0000269|PubMed:12396720}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 ATP = 5'-triphosphoadenylyl-(2'->5')-adenylyl-(2'->5')-
CC         adenosine + 2 diphosphate; Xref=Rhea:RHEA:34407, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:67143; EC=2.7.7.84;
CC         Evidence={ECO:0000269|PubMed:12396720, ECO:0000269|PubMed:15899864,
CC         ECO:0000269|PubMed:2171206, ECO:0000305|PubMed:27663720};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Produced as a latent enzyme which is activated by
CC       dsRNA generated during the course of viral infection. The dsRNA
CC       activator must be at least 15 nucleotides long, and no modification of
CC       the 2'-hydroxyl group is tolerated. ssRNA or dsDNA do not act as
CC       activators.
CC   -!- SUBUNIT: Monomer (By similarity). Homotetramer (By similarity).
CC       Interacts with OAS1D; the interaction inhibits OAS1A catalytic activity
CC       (PubMed:15899864). {ECO:0000250|UniProtKB:P00973,
CC       ECO:0000269|PubMed:15899864}.
CC   -!- INTERACTION:
CC       P11928; O89168; Xeno; NbExp=5; IntAct=EBI-9352099, EBI-10107989;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15899864}.
CC       Mitochondrion {ECO:0000250|UniProtKB:P00973}. Nucleus
CC       {ECO:0000250|UniProtKB:P00973}. Microsome
CC       {ECO:0000250|UniProtKB:P00973}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P00973}. Note=Associated with different
CC       subcellular fractions such as mitochondrial, nuclear, and rough/smooth
CC       microsomal fractions. {ECO:0000250|UniProtKB:P00973}.
CC   -!- TISSUE SPECIFICITY: Expressed in oocytes and granulosa cells of ovary,
CC       in intestine, stomach, spleen and uterus (at protein level)
CC       (PubMed:15899864). Expressed at high levels in the digestive tract and
CC       lymphoid organs (PubMed:12396720). Expressed in ovary and spleen
CC       (PubMed:27663720). {ECO:0000269|PubMed:12396720,
CC       ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:27663720}.
CC   -!- DEVELOPMENTAL STAGE: Detected 5 weeks after birth in developing ovary
CC       and spleen (PubMed:27663720). Expressed in fully grown, germinal
CC       vesicle (GV)-intact oocytes, in oocytes at the metaphase II stage and
CC       in the 2- to 8-cell embryos (PubMed:15899864).
CC       {ECO:0000269|PubMed:15899864, ECO:0000269|PubMed:27663720}.
CC   -!- INDUCTION: Up-regulated in response to the type I interferon IFNB1, in
CC       a STAT1 and STAT2-dependent manner (PubMed:1709495, PubMed:22305621).
CC       Induced by polyinosinic:polycytidylic acid (poly I:C) (PubMed:15899864,
CC       PubMed:27663720). {ECO:0000269|PubMed:15899864,
CC       ECO:0000269|PubMed:1709495, ECO:0000269|PubMed:22305621,
CC       ECO:0000269|PubMed:27663720}.
CC   -!- SIMILARITY: Belongs to the 2-5A synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X04958; CAA28620.1; -; mRNA.
DR   EMBL; M33863; AAA37116.1; -; mRNA.
DR   EMBL; AK149613; BAE28990.1; -; mRNA.
DR   EMBL; AC015535; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466529; EDL19743.1; -; Genomic_DNA.
DR   EMBL; BC013715; AAH13715.1; -; mRNA.
DR   EMBL; BC057878; AAH57878.1; -; mRNA.
DR   EMBL; X58077; CAA41105.1; -; mRNA.
DR   CCDS; CCDS19630.1; -.
DR   PIR; A24725; SYMSO1.
DR   PIR; S15660; S15660.
DR   RefSeq; NP_660212.2; NM_145211.2.
DR   SMR; P11928; -.
DR   BioGRID; 232938; 1.
DR   IntAct; P11928; 1.
DR   STRING; 10090.ENSMUSP00000079198; -.
DR   PhosphoSitePlus; P11928; -.
DR   SwissPalm; P11928; -.
DR   EPD; P11928; -.
DR   MaxQB; P11928; -.
DR   PaxDb; P11928; -.
DR   PeptideAtlas; P11928; -.
DR   PRIDE; P11928; -.
DR   ProteomicsDB; 293916; -.
DR   DNASU; 246730; -.
DR   Ensembl; ENSMUST00000080322; ENSMUSP00000079198; ENSMUSG00000052776.
DR   GeneID; 246730; -.
DR   KEGG; mmu:246730; -.
DR   UCSC; uc008zij.2; mouse.
DR   CTD; 246730; -.
DR   MGI; MGI:2180860; Oas1a.
DR   eggNOG; KOG0001; Eukaryota.
DR   GeneTree; ENSGT00510000046406; -.
DR   HOGENOM; CLU_040930_0_0_1; -.
DR   InParanoid; P11928; -.
DR   OMA; HWYQKCK; -.
DR   OrthoDB; 611234at2759; -.
DR   TreeFam; TF329749; -.
DR   BioGRID-ORCS; 246730; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Oas1a; mouse.
DR   PRO; PR:P11928; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; P11928; protein.
DR   Bgee; ENSMUSG00000052776; Expressed in bone marrow macrophage and 47 other tissues.
DR   Genevisible; P11928; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0001730; F:2'-5'-oligoadenylate synthetase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051607; P:defense response to virus; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IBA:GO_Central.
DR   GO; GO:0048525; P:negative regulation of viral process; IDA:MGI.
DR   GO; GO:0006164; P:purine nucleotide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0060700; P:regulation of ribonuclease activity; IBA:GO_Central.
DR   GO; GO:0009615; P:response to virus; TAS:UniProtKB.
DR   CDD; cd05400; NT_2-5OAS_ClassI-CCAase; 1.
DR   Gene3D; 1.10.1410.20; -; 1.
DR   Gene3D; 3.30.460.10; -; 1.
DR   InterPro; IPR018952; 2-5-oligoAdlate_synth_1_dom2/C.
DR   InterPro; IPR038121; 2-5-oligoAdlate_synth_2_sf.
DR   InterPro; IPR026774; 2-5A_synthase.
DR   InterPro; IPR006117; 2-5OAS_C_CS.
DR   InterPro; IPR043518; 2-5OAS_N_CS.
DR   InterPro; IPR006116; NT_2-5OAS_ClassI-CCAase.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR002934; Polymerase_NTP_transf_dom.
DR   PANTHER; PTHR11258; PTHR11258; 1.
DR   Pfam; PF01909; NTP_transf_2; 1.
DR   Pfam; PF10421; OAS1_C; 1.
DR   SUPFAM; SSF81301; SSF81301; 1.
DR   PROSITE; PS00832; 25A_SYNTH_1; 1.
DR   PROSITE; PS00833; 25A_SYNTH_2; 1.
DR   PROSITE; PS50152; 25A_SYNTH_3; 1.
PE   1: Evidence at protein level;
KW   Antiviral defense; ATP-binding; Cytoplasm; Endoplasmic reticulum; Immunity;
KW   Innate immunity; Magnesium; Metal-binding; Microsome; Mitochondrion;
KW   Nucleotide-binding; Nucleotidyltransferase; Nucleus; Reference proteome;
KW   RNA-binding; Transferase.
FT   CHAIN           1..367
FT                   /note="2'-5'-oligoadenylate synthase 1A"
FT                   /id="PRO_0000160260"
FT   REGION          14..61
FT                   /note="Interaction with dsRNA"
FT                   /evidence="ECO:0000250"
FT   REGION          201..211
FT                   /note="Interaction with dsRNA"
FT                   /evidence="ECO:0000250"
FT   METAL           76
FT                   /note="Magnesium; catalytic"
FT                   /evidence="ECO:0000250"
FT   METAL           78
FT                   /note="Magnesium; catalytic"
FT                   /evidence="ECO:0000250"
FT   METAL           149
FT                   /note="Magnesium; catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         64
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         211
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P29728"
FT   BINDING         214
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         231
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   CONFLICT        74
FT                   /note="K -> R (in Ref. 1; CAA28620 and 2; AAA37116)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176
FT                   /note="E -> W (in Ref. 8; CAA41105)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        240
FT                   /note="F -> Y (in Ref. 8; CAA41105)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249
FT                   /note="Y -> N (in Ref. 8; CAA41105)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        283
FT                   /note="Q -> K (in Ref. 8; CAA41105)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        329
FT                   /note="L -> V (in Ref. 7; AAH57878/AAH13715)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   367 AA;  42429 MW;  AE5946D5807776A4 CRC64;
     MEHGLRSIPA WTLDKFIEDY LLPDTTFGAD VKSAVNVVCD FLKERCFQGA AHPVRVSKVV
     KGGSSGKGTT LKGKSDADLV VFLNNLTSFE DQLNRRGEFI KEIKKQLYEV QHERRFRVKF
     EVQSSWWPNA RSLSFKLSAP HLHQEVEFDV LPAFDVLGHV NTSSKPDPRI YAILIEECTS
     LGKDGEFSTC FTELQRNFLK QRPTKLKSLI RLVKHWYQLC KEKLGKPLPP QYALELLTVF
     AWEQGNGCYE FNTAQGFRTV LELVINYQHL RIYWTKYYDF QHQEVSKYLH RQLRKARPVI
     LDPADPTGNV AGGNPEGWRR LAEEADVWLW YPCFIKKDGS RVSSWDVPTV VPVPFEQVEE
     NWTCILL
//
